344 related articles for article (PubMed ID: 15661874)
1. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo.
Beers C; Burich A; Kleijmeer MJ; Griffith JM; Wong P; Rudensky AY
J Immunol; 2005 Feb; 174(3):1205-12. PubMed ID: 15661874
[TBL] [Abstract][Full Text] [Related]
2. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
[TBL] [Abstract][Full Text] [Related]
3. A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation.
Hsieh CS; deRoos P; Honey K; Beers C; Rudensky AY
J Immunol; 2002 Mar; 168(6):2618-25. PubMed ID: 11884425
[TBL] [Abstract][Full Text] [Related]
4. Lysosomal cysteine proteases and antigen presentation.
Rudensky A; Beers C
Ernst Schering Res Found Workshop; 2006; (56):81-95. PubMed ID: 16329647
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands.
Honey K; Nakagawa T; Peters C; Rudensky A
J Exp Med; 2002 May; 195(10):1349-58. PubMed ID: 12021314
[TBL] [Abstract][Full Text] [Related]
6. Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation.
Maurer D; Fiebiger E; Reininger B; Ebner C; Petzelbauer P; Shi GP; Chapman HA; Stingl G
J Immunol; 1998 Sep; 161(6):2731-9. PubMed ID: 9743330
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus.
Nakagawa T; Roth W; Wong P; Nelson A; Farr A; Deussing J; Villadangos JA; Ploegh H; Peters C; Rudensky AY
Science; 1998 Apr; 280(5362):450-3. PubMed ID: 9545226
[TBL] [Abstract][Full Text] [Related]
8. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.
Shi GP; Bryant RA; Riese R; Verhelst S; Driessen C; Li Z; Bromme D; Ploegh HL; Chapman HA
J Exp Med; 2000 Apr; 191(7):1177-86. PubMed ID: 10748235
[TBL] [Abstract][Full Text] [Related]
9. Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs.
Bania J; Gatti E; Lelouard H; David A; Cappello F; Weber E; Camosseto V; Pierre P
Proc Natl Acad Sci U S A; 2003 May; 100(11):6664-9. PubMed ID: 12748383
[TBL] [Abstract][Full Text] [Related]
10. The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation.
Nakagawa TY; Rudensky AY
Immunol Rev; 1999 Dec; 172():121-9. PubMed ID: 10631942
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells.
Costantino CM; Ploegh HL; Hafler DA
J Immunol; 2009 Jul; 183(2):945-52. PubMed ID: 19553543
[TBL] [Abstract][Full Text] [Related]
12. Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S.
Riese RJ; Shi GP; Villadangos J; Stetson D; Driessen C; Lennon-Dumenil AM; Chu CL; Naumov Y; Behar SM; Ploegh H; Locksley R; Chapman HA
Immunity; 2001 Dec; 15(6):909-19. PubMed ID: 11754813
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis.
Tolosa E; Li W; Yasuda Y; Wienhold W; Denzin LK; Lautwein A; Driessen C; Schnorrer P; Weber E; Stevanovic S; Kurek R; Melms A; Bromme D
J Clin Invest; 2003 Aug; 112(4):517-26. PubMed ID: 12925692
[TBL] [Abstract][Full Text] [Related]
14. Effect of decreasing the affinity of the class II-associated invariant chain peptide on the MHC class II peptide repertoire in the presence or absence of H-2M.
Honey K; Forbush K; Jensen PE; Rudensky AY
J Immunol; 2004 Apr; 172(7):4142-50. PubMed ID: 15034026
[TBL] [Abstract][Full Text] [Related]
15. Proteases, processing, and thymic selection.
Cresswell P
Science; 1998 Apr; 280(5362):394-5. PubMed ID: 9575085
[No Abstract] [Full Text] [Related]
16. Cathepsin S activity regulates antigen presentation and immunity.
Riese RJ; Mitchell RN; Villadangos JA; Shi GP; Palmer JT; Karp ER; De Sanctis GT; Ploegh HL; Chapman HA
J Clin Invest; 1998 Jun; 101(11):2351-63. PubMed ID: 9616206
[TBL] [Abstract][Full Text] [Related]
17. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice.
Nakagawa TY; Brissette WH; Lira PD; Griffiths RJ; Petrushova N; Stock J; McNeish JD; Eastman SE; Howard ED; Clarke SR; Rosloniec EF; Elliott EA; Rudensky AY
Immunity; 1999 Feb; 10(2):207-17. PubMed ID: 10072073
[TBL] [Abstract][Full Text] [Related]
18. Proteases involved in MHC class II antigen presentation.
Villadangos JA; Bryant RA; Deussing J; Driessen C; Lennon-Duménil AM; Riese RJ; Roth W; Saftig P; Shi GP; Chapman HA; Peters C; Ploegh HL
Immunol Rev; 1999 Dec; 172():109-20. PubMed ID: 10631941
[TBL] [Abstract][Full Text] [Related]
19. Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain.
Mizuochi T; Yee ST; Kasai M; Kakiuchi T; Muno D; Kominami E
Immunol Lett; 1994 Dec; 43(3):189-93. PubMed ID: 7721331
[TBL] [Abstract][Full Text] [Related]
20. Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells.
Haque A; Hajiaghamohseni LM; Li P; Toomy K; Blum JS
Cell Immunol; 2007 Sep; 249(1):20-9. PubMed ID: 18067883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]